<SEC-DOCUMENT>0000950170-22-016122-index.html : 20220809
<SEC-HEADER>0000950170-22-016122.hdr.sgml : 20220809
<ACCEPTANCE-DATETIME>20220809163622
ACCESSION NUMBER:		0000950170-22-016122
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20220809
FILED AS OF DATE:		20220809
DATE AS OF CHANGE:		20220809

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Achilles Therapeutics plc
		CENTRAL INDEX KEY:			0001830749
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40299
		FILM NUMBER:		221148935

	BUSINESS ADDRESS:	
		STREET 1:		245 HAMMERSMITH ROAD
		CITY:			LONDON
		STATE:			X0
		ZIP:			W6 8PW
		BUSINESS PHONE:		44 (0)20 8154 4600

	MAIL ADDRESS:	
		STREET 1:		245 HAMMERSMITH ROAD
		CITY:			LONDON
		STATE:			X0
		ZIP:			W6 8PW

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Achilles Therapeutics Ltd
		DATE OF NAME CHANGE:	20201030
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>achl-2022-6-k_q2_2022.htm
<DESCRIPTION>6-K
<TEXT>
Document 1 - file: achl-2022-6-k_q2_2022.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>achl-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: achl-ex99_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>achl-ex99_2.htm
<DESCRIPTION>EX-99.2
<TEXT>
Document 3 - file: achl-ex99_2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>achl-ex99_3.htm
<DESCRIPTION>EX-99.3
<TEXT>
Document 4 - file: achl-ex99_3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img60901631_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: img60901631_0.jpg

</DOCUMENT>
</SEC-DOCUMENT>